Baricitinib Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2 mg, 4 mg
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
Category: Anti Covid Medicines
Baricitinib is available in Tablet and strengths such as 2 mg, 4 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Baricitinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Baricitinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Baricitinib, marketed as Olumiant® by Eli Lilly, is a JAK inhibitor approved in the US and EU for rheumatoid arthritis and authorized for COVID-19 treatment in hospitalized adults. Available in 1 mg, 2 mg, and 4 mg oral tablets, it helps reduce inflammation and cytokine storms in severe COVID-19 cases. Through leading PharmaB2B platforms, global buyers can source Olumiant or Baricitinib generics from GMP-certified manufacturers in India, China, and Bangladesh. Ideal for hospital tenders and bulk procurement, Baricitinib is widely distributed with full regulatory support, competitive pricing, and fast international shipping.
Frequently Asked Questions
Related Products
Nirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Tocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Favipiravir Tablet
Strength: 200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers